The Vpr protein from HIV-1: distinct roles along the viral life cycle (original) (raw)

References

Tristem M, Marshall C, Karpas A, Hill F: Evolution of the primate lentiviruses: evidence from vpx and vpr. Embo J. 1992, 11: 3405-3412.
PubMed Central CAS PubMed Google Scholar
Hoch J, Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Dittmer U, Hunsmann G, Fuchs D, Muller J, Sopper S, et al: vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol. 1995, 69: 4807-4813.
PubMed Central CAS PubMed Google Scholar
Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Hunsmann G, Muller J, Muller-Hermelink H, Fuchs D, Wachter H, Daniel MM, et al: Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol. 1993, 67: 902-912.
PubMed Central CAS PubMed Google Scholar
Gibbs JS, Lackner AA, Lang SM, Simon MA, Sehgal PK, Daniel MD, Desrosiers RC: Progression to AIDS in the absence of a gene for vpr or vpx. J Virol. 1995, 69: 2378-2383.
PubMed Central CAS PubMed Google Scholar
Hirsch VM, Sharkey ME, Brown CR, Brichacek B, Goldstein S, Wakefield J, Byrum R, Elkins WR, Hahn BH, Lifson JD, Stevenson M: Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med. 1998, 4: 1401-1408. 10.1038/3992.
CAS PubMed Google Scholar
Henklein P, Bruns K, Sherman MP, Tessmer U, Licha K, Kopp J, de Noronha CM, Greene WC, Wray V, Schubert U: Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J Biol Chem. 2000, 275: 32016-32026. 10.1074/jbc.M004044200.
CAS PubMed Google Scholar
Schuler W, Wecker K, de Rocquigny H, Baudat Y, Sire J, Roques BP: NMR structure of the (52–96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J Mol Biol. 1999, 285: 2105-2117. 10.1006/jmbi.1998.2381.
CAS PubMed Google Scholar
Wecker K, Roques BP: NMR structure of the (1–51) N-terminal domain of the HIV-1 regulatory protein Vpr. Eur J Biochem. 1999, 266: 359-369. 10.1046/j.1432-1327.1999.00858.x.
CAS PubMed Google Scholar
Wecker K, Morellet N, Bouaziz S, Roques BP: NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1–51) and C-terminal (52–96) domains. Eur J Biochem. 2002, 269: 3779-3788. 10.1046/j.1432-1033.2002.03067.x.
CAS PubMed Google Scholar
Yao XJ, Subbramanian RA, Rougeau N, Boisvert F, Bergeron D, Cohen EA: Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol. 1995, 69: 7032-7044.
PubMed Central CAS PubMed Google Scholar
Bourbigot S, Beltz H, Denis J, Morellet N, Roques BP, Mely Y, Bouaziz S: The C-terminal domain of VPR adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. Biochem J. 2004,
Google Scholar
Wang L, Mukherjee S, Narayan O, Zhao LJ: Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1. Gene. 1996, 178: 7-13. 10.1016/0378-1119(96)00312-5.
CAS PubMed Google Scholar
Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Weiner DB: Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol. 1997, 71: 6339-6347.
PubMed Central CAS PubMed Google Scholar
Zhao LJ, Wang L, Mukherjee S, Narayan O: Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J Biol Chem. 1994, 269: 32131-32137.
CAS PubMed Google Scholar
Morellet N, Bouaziz S, Petitjean P, Roques BP: NMR structure of the HIV-1 regulatory protein VPR. J Mol Biol. 2003, 327: 215-227. 10.1016/S0022-2836(03)00060-3.
CAS PubMed Google Scholar
Bruns K, Fossen T, Wray V, Henklein P, Tessmer U, Schubert U: Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism. J Biol Chem. 2003, 278: 43188-43201. 10.1074/jbc.M305413200.
CAS PubMed Google Scholar
Zander K, Sherman MP, Tessmer U, Bruns K, Wray V, Prechtel AT, Schubert E, Henklein P, Luban J, Neidleman J, et al: Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J Biol Chem. 2003, 278: 43202-43213. 10.1074/jbc.M305414200.
CAS PubMed Google Scholar
Sherman MP, Schubert U, Williams SA, de Noronha CM, Kreisberg JF, Henklein P, Greene WC: HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology. 2002, 302: 95-105. 10.1006/viro.2002.1576.
CAS PubMed Google Scholar
Kichler A, Pages JC, Leborgne C, Druillennec S, Lenoir C, Coulaud D, Delain E, Le Cam E, Roques BP, Danos O: Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J Virol. 2000, 74: 5424-5431. 10.1128/JVI.74.12.5424-5431.2000.
PubMed Central CAS PubMed Google Scholar
Coeytaux E, Coulaud D, Le Cam E, Danos O, Kichler A: The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem. 2003, 278: 18110-18116. 10.1074/jbc.M300248200.
CAS PubMed Google Scholar
Accola MA, Bukovsky AA, Jones MS, Gottlinger HG: A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm). J Virol. 1999, 73: 9992-9999.
PubMed Central CAS PubMed Google Scholar
Bachand F, Yao XJ, Hrimech M, Rougeau N, Cohen EA: Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J Biol Chem. 1999, 274: 9083-9091. 10.1074/jbc.274.13.9083.
CAS PubMed Google Scholar
Jenkins Y, Sanchez PV, Meyer BE, Malim MH: Nuclear export of human immunodeficiency virus type 1 Vpr is not required for virion packaging. J Virol. 2001, 75: 8348-8352. 10.1128/JVI.75.17.8348-8352.2001.
PubMed Central CAS PubMed Google Scholar
Selig L, Pages JC, Tanchou V, Preveral S, Berlioz-Torrent C, Liu LX, Erdtmann L, Darlix J, Benarous R, Benichou S: Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J Virol. 1999, 73: 592-600.
PubMed Central CAS PubMed Google Scholar
Singh SP, Tomkowicz B, Lai D, Cartas M, Mahalingam S, Kalyanaraman VS, Murali R, Srinivasan A: Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr. J Virol. 2000, 74: 10650-10657. 10.1128/JVI.74.22.10650-10657.2000.
PubMed Central CAS PubMed Google Scholar
Kondo E, Gottlinger HG: A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. J Virol. 1996, 70: 159-164.
PubMed Central CAS PubMed Google Scholar
Accola MA, Ohagen A, Gottlinger HG: Isolation of human immunodeficiency virus type 1 cores: retention of vpr in the absence of p6(gag) [In Process Citation]. J Virol. 2000, 74: 6198-6202. 10.1128/JVI.74.13.6198-6202.2000.
PubMed Central CAS PubMed Google Scholar
Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG: Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol. 2000, 74: 1168-1177. 10.1128/JVI.74.3.1168-1177.2000.
PubMed Central CAS PubMed Google Scholar
Zhang S, Pointer D, Singer G, Feng Y, Park K, Zhao LJ: Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene. 1998, 212: 157-166. 10.1016/S0378-1119(98)00178-4.
CAS PubMed Google Scholar
de Rocquigny H, Caneparo A, Delaunay T, Bischerour J, Mouscadet JF, Roques BP: Interactions of the C-terminus of viral protein R with nucleic acids are modulated by its N-terminus. Eur J Biochem. 2000, 267: 3654-3660. 10.1046/j.1432-1327.2000.01397.x.
CAS PubMed Google Scholar
de Rocquigny H, Petitjean P, Tanchou V, Decimo D, Drouot L, Delaunay T, Darlix JL, Roques BP: The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol Chem. 1997, 272: 30753-30759. 10.1074/jbc.272.49.30753.
CAS PubMed Google Scholar
Sato A, Yoshimoto J, Isaka Y, Miki S, Suyama A, Adachi A, Hayami M, Fujiwara T, Yoshie O: Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. Virology. 1996, 220: 208-212. 10.1006/viro.1996.0302.
CAS PubMed Google Scholar
Muller B, Tessmer U, Schubert U, Krausslich HG: Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J Virol. 2000, 74: 9727-9731. 10.1128/JVI.74.20.9727-9731.2000.
PubMed Central CAS PubMed Google Scholar
Wu X, Liu H, Xiao H, Kim J, Seshaiah P, Natsoulis G, Boeke JD, Hahn BH, Kappes JC: Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol. 1995, 69: 3389-3398.
PubMed Central CAS PubMed Google Scholar
Yao XJ, Kobinger G, Dandache S, Rougeau N, Cohen E: HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect. Gene Ther. 1999, 6: 1590-1599. 10.1038/sj.gt.3300988.
CAS PubMed Google Scholar
Wu X, Liu H, Xiao H, Conway JA, Hunter E, Kappes JC: Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. Embo J. 1997, 16: 5113-5122. 10.1093/emboj/16.16.5113.
PubMed Central CAS PubMed Google Scholar
Liu H, Wu X, Xiao H, Kappes JC: Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1. J Virol. 1999, 73: 8831-8836.
PubMed Central CAS PubMed Google Scholar
Wu X, Liu H, Xiao H, Conway JA, Hehl E, Kalpana GV, Prasad V, Kappes JC: Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol. 1999, 73: 2126-2135.
PubMed Central CAS PubMed Google Scholar
Padow M, Lai L, Deivanayagam C, DeLucas LJ, Weiss RB, Dunn DM, Wu X, Kappes JC: Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis. J Virol. 2003, 77: 11050-11059. 10.1128/JVI.77.20.11050-11059.2003.
PubMed Central CAS PubMed Google Scholar
McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ: Visualization of the intracellular behavior of HIV in living cells. J Cell Biol. 2002, 159: 441-452. 10.1083/jcb.200203150.
PubMed Central CAS PubMed Google Scholar
McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ: Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science. 2003, 300: 1295-1297. 10.1126/science.1084238.
CAS PubMed Google Scholar
Farnet CM, Haseltine WA: Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol. 1991, 65: 1910-1915.
PubMed Central CAS PubMed Google Scholar
Fassati A, Goff SP: Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol. 2001, 75: 3626-3635. 10.1128/JVI.75.8.3626-3635.2001.
PubMed Central CAS PubMed Google Scholar
Miller MD, Farnet CM, Bushman FD: Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol. 1997, 71: 5382-5390.
PubMed Central CAS PubMed Google Scholar
Nermut MV, Fassati A: Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J Virol. 2003, 77: 8196-8206. 10.1128/JVI.77.15.8196-8206.2003.
PubMed Central CAS PubMed Google Scholar
Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells [see comments]. Nature. 1993, 365: 666-669. 10.1038/365666a0.
CAS PubMed Google Scholar
Goff SP: Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J Gene Med. 2001, 3: 517-528. 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E.
CAS PubMed Google Scholar
Zhang H, Dornadula G, Orenstein J, Pomerantz RJ: Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core. J Hum Virol. 2000, 3: 165-172.
CAS PubMed Google Scholar
Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM: Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. Embo J. 2003, 22: 3675-3685. 10.1093/emboj/cdg357.
PubMed Central CAS PubMed Google Scholar
Stark LA, Hay RT: Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription. J Virol. 1998, 72: 3037-3044.
PubMed Central CAS PubMed Google Scholar
Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995, 69: 5087-5094.
PubMed Central CAS PubMed Google Scholar
Mansky LM: The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. Virology. 1996, 222: 391-400. 10.1006/viro.1996.0436.
CAS PubMed Google Scholar
Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S: Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J Biol Chem. 2004, 279: 28419-28425. 10.1074/jbc.M403875200.
CAS PubMed Google Scholar
Mansky LM, Preveral S, Selig L, Benarous R, Benichou S: The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficienty virus type 1 in vivo mutation rates. J Virol. 2000, 74: 7039-7047. 10.1128/JVI.74.15.7039-7047.2000.
PubMed Central CAS PubMed Google Scholar
Agostini I, Navarro JM, Bouhamdan M, Willetts K, Rey F, Spire B, Vigne R, Pomerantz R, Sire J: The HIV-1 Vpr co-activator induces a conformational change in TFIIB. FEBS Lett. 1999, 450: 235-239. 10.1016/S0014-5793(99)00501-3.
CAS PubMed Google Scholar
Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, et al: The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med. 2000, 191: 33-46. 10.1084/jem.191.1.33.
PubMed Central CAS PubMed Google Scholar
Klarmann GJ, Chen X, North TW, Preston BD: Incorporation of uracil into minus strand DNA affects the specificity of plus strand synthesis initiation during lentiviral reverse transcription. J Biol Chem. 2003, 278: 7902-7909. 10.1074/jbc.M207223200.
CAS PubMed Google Scholar
Chen R, Wang H, Mansky LM: Roles of uracil-DNA glycosylase and dUTPase in virus replication. J Gen Virol. 2002, 83: 2339-2345.
CAS PubMed Google Scholar
Sheehy AM, Gaddis NC, Choi JD, Malim MH: Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002, 418: 646-650. 10.1038/nature00939.
CAS PubMed Google Scholar
Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L: The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 2003, 424: 94-98. 10.1038/nature01707.
PubMed Central CAS PubMed Google Scholar
Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR: Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 2003, 114: 21-31. 10.1016/S0092-8674(03)00515-4.
CAS PubMed Google Scholar
Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D: Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003, 424: 99-103. 10.1038/nature01709.
CAS PubMed Google Scholar
Lecossier D, Bouchonnet F, Clavel F, Hance AJ: Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 2003, 300: 1112-10.1126/science.1083338.
CAS PubMed Google Scholar
Cohen OJ, Fauci AS: Current strategies in the treatment of HIV infection. Adv Intern Med. 2001, 46: 207-246.
CAS PubMed Google Scholar
Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, Greene WC, Goldsmith MA: HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med. 2001, 194: 1407-1419. 10.1084/jem.194.10.1407.
PubMed Central CAS PubMed Google Scholar
Greber UF, Fassati A: Nuclear import of viral DNA genomes. Traffic. 2003, 4: 136-143.
CAS PubMed Google Scholar
Connor RI, Chen BK, Choe S, Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995, 206: 935-944. 10.1006/viro.1995.1016.
CAS PubMed Google Scholar
Gallay P, Stitt V, Mundy C, Oettinger M, Trono D: Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J Virol. 1996, 70: 1027-1032.
PubMed Central CAS PubMed Google Scholar
Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M: The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A. 1994, 91: 7311-7315.
PubMed Central CAS PubMed Google Scholar
Le Rouzic E, Mousnier A, Rustum C, Stutz F, Hallberg E, Dargemont C, Benichou S: Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J Biol Chem. 2002, 277: 45091-45098. 10.1074/jbc.M207439200.
CAS PubMed Google Scholar
Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M: Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J Biol Chem. 1998, 273: 13347-13352. 10.1074/jbc.273.21.13347.
CAS PubMed Google Scholar
Popov S, Rexach M, Zybarth G, Reiling N, Lee MA, Ratner L, Lane CM, Moore MS, Blobel G, Bukrinsky M: Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. Embo J. 1998, 17: 909-917. 10.1093/emboj/17.4.909.
PubMed Central CAS PubMed Google Scholar
Vodicka MA, Koepp DM, Silver PA, Emerman M: HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 1998, 12: 175-185.
PubMed Central CAS PubMed Google Scholar
Fouchier RA, Meyer BE, Simon JH, Fischer U, Albright AV, Gonzalez-Scarano F, Malim MH: Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J Virol. 1998, 72: 6004-6013.
PubMed Central CAS PubMed Google Scholar
Fouchier RA, Malim MH: Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv Virus Res. 1999, 52: 275-299.
CAS PubMed Google Scholar
Cullen BR: Journey to the center of the cell. Cell. 2001, 105: 697-700. 10.1016/S0092-8674(01)00392-0.
CAS PubMed Google Scholar
Bukrinsky M, Adzhubei A: Viral protein R of HIV-1. Rev Med Virol. 1999, 9: 39-49. 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.3.CO;2-V.
CAS PubMed Google Scholar
Bukrinskaya A, Brichacek B, Mann A, Stevenson M: Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J Exp Med. 1998, 188: 2113-2125. 10.1084/jem.188.11.2113.
PubMed Central CAS PubMed Google Scholar
Waldhuber MG, Bateson M, Tan J, Greenway AL, McPhee DA: Studies with GFP-Vpr fusion proteins: induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization. Virology. 2003, 313: 91-104. 10.1016/S0042-6822(03)00258-7.
CAS PubMed Google Scholar
Kamata M, Aida Y: Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms. J Virol. 2000, 74: 7179-7186. 10.1128/JVI.74.15.7179-7186.2000.
PubMed Central CAS PubMed Google Scholar
Depienne C, Roques P, Creminon C, Fritsch L, Casseron R, Dormont D, Dargemont C, Benichou S: Cellular Distribution and Karyophilic Properties of Matrix, Integrase, and Vpr Proteins from the Human and Simian Immunodeficiency Viruses. Exp Cell Res. 2000, 260: 387-395. 10.1006/excr.2000.5016.
CAS PubMed Google Scholar
Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ: Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol. 2002, 26: 915-927. 10.1083/jcb.200206106.
Google Scholar
Rout MP, Aitchison JD: The nuclear pore complex as a transport machine. J Biol Chem. 2001, 276: 16593-16596. 10.1074/jbc.R100015200.
CAS PubMed Google Scholar
Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG: Efficient HIV-1 replication can occur in the absence of the viral matrix protein. Embo J. 1998, 17: 2699-2708. 10.1093/emboj/17.9.2699.
PubMed Central CAS PubMed Google Scholar
Haffar OK, Popov S, Dubrovsky L, Agostini I, Tang H, Pushkarsky T, Nadler SG, Bukrinsky M: Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol. 2000, 299: 359-368. 10.1006/jmbi.2000.3768.
CAS PubMed Google Scholar
Dupont S, Sharova N, DeHoratius C, Virbasius CM, Zhu X, Bukrinskaya AG, Stevenson M, Green MR: A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature. 1999, 402: 681-685. 10.1038/45272.
CAS PubMed Google Scholar
de Noronha CM, Sherman MP, Lin HW, Cavrois MV, Moir RD, Goldman RD, Greene WC: Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science. 2001, 294: 1105-1108. 10.1126/science.1063957.
CAS PubMed Google Scholar
Segura-Totten M, Wilson KL: Virology. HIV – breaking the rules for nuclear entry. Science. 2001, 294: 1016-1017. 10.1126/science.1066729.
CAS PubMed Google Scholar
Lu YL, Spearman P, Ratner L: Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol. 1993, 67: 6542-6550.
PubMed Central CAS PubMed Google Scholar
Zhou Y, Lu Y, Ratner L: Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest. Virology. 1998, 242: 414-424. 10.1006/viro.1998.9028.
CAS PubMed Google Scholar
Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR: Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol. 1995, 69: 7909-7916.
PubMed Central CAS PubMed Google Scholar
Jenkins Y, McEntee M, Weis K, Greene WC: Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J Cell Biol. 1998, 143: 875-885. 10.1083/jcb.143.4.875.
PubMed Central CAS PubMed Google Scholar
Subbramanian RA, Yao XJ, Dilhuydy H, Rougeau N, Bergeron D, Robitaille Y, Cohen EA: Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. J Mol Biol. 1998, 278: 13-30. 10.1006/jmbi.1998.1685.
CAS PubMed Google Scholar
Karni O, Friedler A, Zakai N, Gilon C, Loyter A: A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr. FEBS Lett. 1998, 429: 421-425. 10.1016/S0014-5793(98)00645-0.
CAS PubMed Google Scholar
Bukrinsky MI, Haffar OK: HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr. Mol Med. 1998, 4: 138-143.
PubMed Central CAS PubMed Google Scholar
Agostini I, Popov S, Li J, Dubrovsky L, Hao T, Bukrinsky M: Heat-Shock Protein 70 Can Replace Viral Protein R of HIV-1 during Nuclear Import of the Viral Preintegration Complex. Exp Cell Res. 2000, 259: 398-403. 10.1006/excr.2000.4992.
CAS PubMed Google Scholar
Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P: HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 2000, 101: 173-185. 10.1016/S0092-8674(00)80828-4.
CAS PubMed Google Scholar
Sherman MP, Greene WC: Slipping through the door: HIV entry into the nucleus. Microbes Infect. 2002, 4: 67-73. 10.1016/S1286-4579(01)01511-8.
CAS PubMed Google Scholar
Sherman MP, de Noronha CM, Heusch MI, Greene S, Greene WC: Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J Virol. 2001, 75: 1522-1532. 10.1128/JVI.75.3.1522-1532.2001.
PubMed Central CAS PubMed Google Scholar
Sherman MP, de Noronha CM, Eckstein LA, Hataye J, Mundt P, Williams SA, Neidleman JA, Goldsmith MA, Greene WC: Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages. J Virol. 2003, 77: 7582-7589. 10.1128/JVI.77.13.7582-7589.2003.
PubMed Central CAS PubMed Google Scholar
Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS: The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol. 1995, 69: 6304-6313.
PubMed Central CAS PubMed Google Scholar
He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR: Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol. 1995, 69: 6705-6711.
PubMed Central CAS PubMed Google Scholar
Re F, Braaten D, Franke EK, Luban J: Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol. 1995, 69: 6859-6864.
PubMed Central CAS PubMed Google Scholar
Bartz SR, Rogel ME, Emerman M: Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol. 1996, 70: 2324-2331.
PubMed Central CAS PubMed Google Scholar
Planelles V, Jowett JB, Li QX, Xie Y, Hahn B, Chen IS: Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol. 1996, 70: 2516-2524.
PubMed Central CAS PubMed Google Scholar
Poon B, Grovit-Ferbas K, Stewart SA, Chen ISY: Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science. 1998, 281: 266-269. 10.1126/science.281.5374.266.
CAS PubMed Google Scholar
Zhang C, Rasmussen C, Chang LJ: Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe. Virology. 1997, 230: 103-112. 10.1006/viro.1997.8459.
CAS PubMed Google Scholar
Zhao Y, Cao J, O'Gorman MR, Yu M, Yogev R: Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol. 1996, 70: 5821-5826.
PubMed Central CAS PubMed Google Scholar
Yao XJ, Lemay J, Rougeau N, Clement M, Kurtz S, Belhumeur P, Cohen EA: Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr. J Biol Chem. 2002, 277: 48816-48826. 10.1074/jbc.M207982200.
CAS PubMed Google Scholar
Bouzar AB, Guiguen F, Morin T, Villet S, Fornazero C, Garnier C, Gallay K, Gounel F, Favier C, Durand J, et al: Specific G2 arrest of caprine cells infected with a caprine arthritis encephalitis virus expressing vpr and vpx genes from simian immunodeficiency virus. Virology. 2003, 309: 41-52. 10.1016/S0042-6822(03)00014-X.
CAS PubMed Google Scholar
Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA, Hahn BH, Emerman M: HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med. 1998, 4: 65-71. 10.1038/nm0198-065.
CAS PubMed Google Scholar
Zhou Y, Ratner L: Phosphorylation of Human Immunodeficiency Virus Type 1 Vpr Regulates Cell Cycle Arrest. J Virol. 2000, 74: 6520-6527. 10.1128/JVI.74.14.6520-6527.2000.
PubMed Central CAS PubMed Google Scholar
Agostini I, Popov S, Hao T, Li JH, Dubrovsky L, Chaika O, Chaika N, Lewis R, Bukrinsky M: Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. AIDS Res Hum Retroviruses. 2002, 18: 283-288. 10.1089/088922202753472856.
CAS PubMed Google Scholar
Nurse P: Checkpoint pathways come of age. Cell. 1997, 91: 865-867. 10.1016/S0092-8674(00)80476-6.
CAS PubMed Google Scholar
Smits VA, Medema RH: Checking out the G(2)/M transition. Biochim Biophys Acta. 2001, 1519: 1-12.
CAS PubMed Google Scholar
Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Kao GD, Muschel RJ, Weiner DB: HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc Natl Acad Sci U S A. 1998, 95: 3419-3424. 10.1073/pnas.95.7.3419.
PubMed Central CAS PubMed Google Scholar
Ramanathan MP, Curley E, Su M, Chambers JA, Weiner DB: Carboxyl terminus of hVIP/mov34 is critical for HIV-1-Vpr interaction and glucocorticoid-mediated signaling. J Biol Chem. 2002, 277: 47854-47860. 10.1074/jbc.M203905200.
CAS PubMed Google Scholar
Gragerov A, Kino T, Ilyina-Gragerova G, Chrousos GP, Pavlakis GN: HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. Virology. 1998, 245: 323-330. 10.1006/viro.1998.9138.
CAS PubMed Google Scholar
Withers-Ward ES, Jowett JB, Stewart SA, Xie YM, Garfinkel A, Shibagaki Y, Chow SA, Shah N, Hanaoka F, Sawitz DG, et al: Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J Virol. 1997, 71: 9732-9742.
PubMed Central CAS PubMed Google Scholar
Bouhamdan M, Benichou S, Rey F, Navarro JM, Agostini I, Spire B, Camonis J, Slupphaug G, Vigne R, Benarous R, Sire J: Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol. 1996, 70: 697-704.
PubMed Central CAS PubMed Google Scholar
Mansky LM, Preveral S, Le Rouzic E, Bernard LC, Selig L, Depienne C, Benarous R, Benichou S: Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. Virology. 2001, 282: 176-185. 10.1006/viro.2000.0791.
CAS PubMed Google Scholar
Selig L, Benichou S, Rogel ME, Wu LI, Vodicka MA, Sire J, Benarous R, Emerman M: Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J Virol. 1997, 71: 4842-4846.
PubMed Central CAS PubMed Google Scholar
Poon B, Jowett JB, Stewart SA, Armstrong RW, Rishton GM, Chen IS: Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J Virol. 1997, 71: 3961-3971.
PubMed Central CAS PubMed Google Scholar
Cliby WA, Lewis KA, Lilly KK, Kaufmann SH: S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J Biol Chem. 2002, 277: 1599-1606. 10.1074/jbc.M106287200.
CAS PubMed Google Scholar
Roshal M, Kim B, Zhu Y, Nghiem P, Planelles V: Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem. 2003, 278: 25879-25886. 10.1074/jbc.M303948200.
CAS PubMed Google Scholar
Hrimech M, Yao XJ, Branton PE, Cohen EA: Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. Embo J. 2000, 19: 3956-3967. 10.1093/emboj/19.15.3956.
PubMed Central CAS PubMed Google Scholar
Zolnierowicz S: Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol. 2000, 60: 1225-1235. 10.1016/S0006-2952(00)00424-X.
CAS PubMed Google Scholar
Masuda M, Nagai Y, Oshima N, Tanaka K, Murakami H, Igarashi H, Okayama H: Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J Virol. 2000, 74: 2636-2646. 10.1128/JVI.74.6.2636-2646.2000.
PubMed Central CAS PubMed Google Scholar
Hagting A, Jackman M, Simpson K, Pines J: Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal. Curr Biol. 1999, 9: 680-689. 10.1016/S0960-9822(99)80308-X.
CAS PubMed Google Scholar
Carr AM: Molecular biology. Beginning at the end. Science. 2003, 300: 1512-1513. 10.1126/science.1085689.
CAS PubMed Google Scholar
Hutchison CJ: Lamins: building blocks or regulators of gene expression?. Nat Rev Mol Cell Biol. 2002, 3: 848-858. 10.1038/nrm950.
CAS PubMed Google Scholar
Alimonti JB, Ball TB, Fowke KR: Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol. 2003, 84: 1649-1661. 10.1099/vir.0.19110-0.
CAS PubMed Google Scholar
Yasuda J, Miyao T, Kamata M, Aida Y, Iwakura Y: T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene. Virology. 2001, 285: 181-192. 10.1006/viro.2001.0964.
CAS PubMed Google Scholar
Ayyavoo V, Mahboubi A, Mahalingam S, Ramalingam R, Kudchodkar S, Williams WV, Green DR, Weiner DB: HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [see comments]. Nat Med. 1997, 3: 1117-1123. 10.1038/nm1097-1117.
CAS PubMed Google Scholar
Conti L, Rainaldi G, Matarrese P, Varano B, Rivabene R, Columba S, Sato A, Belardelli F, Malorni W, Gessani S: The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp Med. 1998, 187: 403-413. 10.1084/jem.187.3.403.
PubMed Central CAS PubMed Google Scholar
Stewart SA, Poon B, Jowett JB, Chen IS: Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol. 1997, 71: 5579-5592.
PubMed Central CAS PubMed Google Scholar
Stewart SA, Poon B, Song JY, Chen IS: Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol. 2000, 74: 3105-3111. 10.1128/JVI.74.7.3105-3111.2000.
PubMed Central CAS PubMed Google Scholar
Watanabe N, Yamaguchi T, Akimoto Y, Rattner JB, Hirano H, Nakauchi H: Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells. Exp Cell Res. 2000, 258: 261-269. 10.1006/excr.2000.4908.
CAS PubMed Google Scholar
Yao XJ, Mouland AJ, Subbramanian RA, Forget J, Rougeau N, Bergeron D, Cohen EA: Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J Virol. 1998, 72: 4686-4693.
PubMed Central CAS PubMed Google Scholar
Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, Green DR, Weiner DB: HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem. 2002, 277: 37820-37831. 10.1074/jbc.M205313200.
CAS PubMed Google Scholar
Nishizawa M, Kamata M, Katsumata R, Aida Y: A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest. J Virol. 2000, 74: 6058-6067. 10.1128/JVI.74.13.6058-6067.2000.
PubMed Central CAS PubMed Google Scholar
Nishizawa M, Kamata M, Mojin T, Nakai Y, Aida Y: Induction of Apoptosis by the Vpr Protein of Human Immunodeficiency Virus Type 1 Occurs Independently of G(2) Arrest of the Cell Cycle. Virology. 2000, 276: 16-26. 10.1006/viro.2000.0534.
CAS PubMed Google Scholar
Yuan H, Xie YM, Chen IS: Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis. J Virol. 2003, 77: 2063-2070. 10.1128/JVI.77.3.2063-2070.2003.
PubMed Central CAS PubMed Google Scholar
Krek W, Nigg EA: Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. Embo J. 1991, 10: 3331-3341.
PubMed Central CAS PubMed Google Scholar
Heald R, McLoughlin M, McKeon F: Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell. 1993, 74: 463-474. 10.1016/0092-8674(93)80048-J.
CAS PubMed Google Scholar
Chang F, Re F, Sebastian S, Sazer S, Luban J: HIV-1 Vpr Induces Defects in Mitosis, Cytokinesis, Nuclear Structure, and Centrosomes. Mol Biol Cell. 2004, 15: 1793-1801. 10.1091/mbc.E03-09-0691.
PubMed Central CAS PubMed Google Scholar
Jacotot E, Ferri KF, El Hamel C, Brenner C, Druillennec S, Hoebeke J, Rustin P, Metivier D, Lenoir C, Geuskens M, et al: Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med. 2001, 193: 509-519. 10.1084/jem.193.4.509.
PubMed Central CAS PubMed Google Scholar
Wang X: The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15: 2922-2933.
CAS PubMed Google Scholar
Roumier T, Vieira HL, Castedo M, Ferri KF, Boya P, Andreau K, Druillennec S, Joza N, Penninger JM, Roques B, Kroemer G: The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ. 2002, 9: 1212-1219. 10.1038/sj.cdd.4401089.
CAS PubMed Google Scholar
Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, Zhang D, Lee MD, Duvvuri U, Weiner DB: Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun. 2003, 304: 583-592. 10.1016/S0006-291X(03)00631-4.
CAS PubMed Google Scholar
Roshal M, Zhu Y, Planelles V: Apoptosis in AIDS. Apoptosis. 2001, 6: 103-116. 10.1023/A:1009636530839.
CAS PubMed Google Scholar
Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, et al: Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest. 2003, 111: 1547-1554. 10.1172/JCI200316233.
PubMed Central CAS PubMed Google Scholar
Jian H, Zhao LJ: Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64. J Biol Chem. 2003, 278: 44326-44330. 10.1074/jbc.C300378200.
CAS PubMed Google Scholar
Levy DN, Refaeli Y, Weiner DB: Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J Virol. 1995, 69: 1243-1252.
PubMed Central CAS PubMed Google Scholar
Levy DN, Refaeli Y, MacGregor RR, Weiner DB: Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1994, 91: 10873-10877.
PubMed Central CAS PubMed Google Scholar
Patel CA, Mukhtar M, Harley S, Kulkosky J, Pomerantz RJ: Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons. J Neurovirol. 2002, 8: 86-99. 10.1080/13550280290049552.
CAS PubMed Google Scholar
Piller SC, Ewart GD, Jans DA, Gage PW, Cox GB: The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J Virol. 1999, 73: 4230-4238.
PubMed Central CAS PubMed Google Scholar
Huang MB, Weeks O, Zhao LJ, Saltarelli M, Bond VC: Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J Neurovirol. 2000, 6: 202-220.
CAS PubMed Google Scholar
Piller SC, Ewart GD, Premkumar A, Cox GB, Gage PW: Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc Natl Acad Sci U S A. 1996, 93: 111-115. 10.1073/pnas.93.1.111.
PubMed Central CAS PubMed Google Scholar
Patel CA, Mukhtar M, Pomerantz RJ: Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol. 2000, 74: 9717-9726. 10.1128/JVI.74.20.9717-9726.2000.
PubMed Central CAS PubMed Google Scholar
Cohen EA, Dehni G, Sodroski JG, Haseltine WA: Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol. 1990, 64: 3097-3099.
PubMed Central CAS PubMed Google Scholar
Ogawa K, Shibata R, Kiyomasu T, Higuchi I, Kishida Y, Ishimoto A, Adachi A: Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol. 1989, 63: 4110-4114.
PubMed Central CAS PubMed Google Scholar
Felzien LK, Woffendin C, Hottiger MO, Subbramanian RA, Cohen EA, Nabel GJ: HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc Natl Acad Sci U S A. 1998, 95: 5281-5286. 10.1073/pnas.95.9.5281.
PubMed Central CAS PubMed Google Scholar
Gummuluru S, Emerman M: Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J Virol. 1999, 73: 5422-5430.
PubMed Central CAS PubMed Google Scholar
Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, Bergeron D, Cohen EA: Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med. 1998, 187: 1103-1111. 10.1084/jem.187.7.1103.
PubMed Central CAS PubMed Google Scholar
Hrimech M, Yao XJ, Bachand F, Rougeau N, Cohen EA: Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J Virol. 1999, 73: 4101-4109.
PubMed Central CAS PubMed Google Scholar
Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B: HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother. 2003, 57: 41-48. 10.1016/S0753-3322(02)00333-5.
CAS PubMed Google Scholar
Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ: Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem. 1995, 270: 25564-25569. 10.1074/jbc.270.43.25564.
CAS PubMed Google Scholar
Vanitharani R, Mahalingam S, Rafaeli Y, Singh SP, Srinivasan A, Weiner DB, Ayyavoo V: HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. Virology. 2001, 289: 334-342. 10.1006/viro.2001.1153.
CAS PubMed Google Scholar
Poon B, Chen IS: Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. J Virol. 2003, 77: 3962-3972. 10.1128/JVI.77.7.3962-3972.2003.
PubMed Central CAS PubMed Google Scholar
Zhu Y, Roshal M, Li F, Blackett J, Planelles V: Upregulation of survivin by HIV-1 Vpr. Apoptosis. 2003, 8: 71-79. 10.1023/A:1021653119934.
CAS PubMed Google Scholar
Roux P, Alfieri C, Hrimech M, Cohen EA, Tanner JE: Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J Virol. 2000, 74: 4658-4665. 10.1128/JVI.74.10.4658-4665.2000.
PubMed Central CAS PubMed Google Scholar
Chowdhury IH, Wang XF, Landau NR, Robb ML, Polonis VR, Birx DL, Kim JH: HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. Virology. 2003, 305: 371-377. 10.1006/viro.2002.1777.
CAS PubMed Google Scholar
Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP: The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med. 1999, 189: 51-62. 10.1084/jem.189.1.51.
PubMed Central CAS PubMed Google Scholar
Refaeli Y, Levy DN, Weiner DB: The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc Natl Acad Sci U S A. 1995, 92: 3621-3625.
PubMed Central CAS PubMed Google Scholar
Hottiger MO, Nabel GJ: Viral replication and the coactivators p300 and CBP. Trends Microbiol. 2000, 8: 560-565. 10.1016/S0966-842X(00)01874-6.
CAS PubMed Google Scholar
Agostini I, Navarro JM, Rey F, Bouhamdan M, Spire B, Vigne R, Sire J: The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol. 1996, 261: 599-606. 10.1006/jmbi.1996.0485.
CAS PubMed Google Scholar
Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S: Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem. 1998, 273: 20052-20057. 10.1074/jbc.273.32.20052.
CAS PubMed Google Scholar
Kino T, Gragerov A, Slobodskaya O, Tsopanomichalou M, Chrousos GP, Pavlakis GN: Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J Virol. 2002, 76: 9724-9734. 10.1128/JVI.76.19.9724-9734.2002.
PubMed Central CAS PubMed Google Scholar
Sherman MP, de Noronha CM, Pearce D, Greene WC: Human immunodeficiency virus type 1 vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest [In Process Citation]. J Virol. 2000, 74: 8159-8165. 10.1128/JVI.74.17.8159-8165.2000.
PubMed Central CAS PubMed Google Scholar
Janket ML, Manickam P, Majumder B, Thotala D, Wagner M, Schafer EA, Collman RG, Srinivasan A, Ayyavoo V: Differential regulation of host cellular genes by HIV-1 viral protein R (Vpr): cDNA microarray analysis using isogenic virus. Biochem Biophys Res Commun. 2004, 314: 1126-1132. 10.1016/j.bbrc.2004.01.008.
CAS PubMed Google Scholar

Download references